Health
News Scan for Apr 19, 2021 – CIDRAP
CARB-X to fund development of bacteriophage-based drug
CARB-X announced today that it is awarding Phico Therapeutics of Cambridge, United Kingdom, up to $5.3 million to develop an intravenous bacteriophage drug to treat ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
The award will support development of Phico’s SASPject PT 3.9 project, which combines engineered bacteriophages with antibacterial small acid-soluble spore proteins (SASPs) to target and inactivate P aeruginosa bacteria….
-
Noosa News22 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre
-
General23 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
General11 hours agoDriver charged after fatal alleged hit-run crash at Hillier
-
General12 hours ago‘Fortune teller’ allegedly defrauds Sydney’s Vietnamese community out of $70 million